1. Immunology/Inflammation Metabolic Enzyme/Protease
  2. COX Carbonic Anhydrase
  3. COX-2-IN-30

COX-2-IN-30 是一种苯磺酰胺衍生物,也是一种具有口服活性的 COX/5-LOX 双重抑制剂,IC50 分别为 49 nM (COX),10.4 μM (5-LOX)。COX-2-IN-30 还抑制跨膜 hCA IXhCA XII 亚型,具有纳摩尔级 Ki 值。COX-2-IN-30 具有镇痛、抗炎和致溃疡活性,并且不显示急性胃效应。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

COX-2-IN-30 Chemical Structure

COX-2-IN-30 Chemical Structure

CAS No. : 1160498-08-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 COX 亚型特异性产品:

查看 Carbonic Anhydrase 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

COX-2-IN-30 is a benzenesulfonamide derivative, as well as an orally active and dual inhibitor of COX (IC50=49 nM for COX-2, 10.4 μM for COX-1) and 5-LOX (IC50=2.4 μM). COX-2-IN-30 also inhibits transmembrane hCA IX and hCA XII isoform with nanomolar calss Ki values. COX-2-IN-30 exhibits analgesic, anti-inflammatory, and ulcerogenic activities, and does not show acute gastric effect[1].

IC50 & Target[1]

COX-2

49 nM (IC50)

COX-1

10.4 μM (IC50)

hCA I

183.4 nM (Ki)

hCA II

81.4 nM (Ki)

hCA IX

38.4 nM (Ki)

hCA XII

21.6 nM (Ki)

5-LOX

2.4 μM (IC50)

体外研究
(In Vitro)

COX-2-IN-30 (化合物 7a) 与 hCA 亚型结合,Ki 值分别为 183.4 nM (hCA I)、81.4 nM (hCA II)、38.4 nM (hCA IX)、21.6 nM (hCA XII)[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

COX-2-IN-30 (化合物 7a) (10 mg/kg;口服;单剂量) 表现出镇痛活性,同时显着减少小鼠的扭动次数[1]
COX-2-IN-30 (10 mg/kg;口服;单次剂量) 在 Carrageenan (HY-125474) 诱导的大鼠爪水肿试验中导致爪高度显着降低。 COX-2-IN-30 显着降低 TNF-α 和 IL-1β 的水平[1]
COX-2-IN-30 (10 mg/kg;口服;单剂量) 在雄性白化病大鼠的胃组织中表现出安全性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Albino mice (25-30 g)[1]
Dosage: 10 mg/kg
Administration: PO; single dose; after one hour, 0.1 mL of 1 percent acetic acid in a volume of 0.1 mL/10 g body weight was used to produce writhing.
Result: Decreased the number of writhing responses of mouse conpared with control group.
Animal Model: Paw edema rat induced by Carrageenan (HY-125474)[1]
Dosage: 10 mg/kg
Administration: PO; single dose; after one hour, 0.1 mL of 1% carrageenan solution was injected in the left hind paw; measure inflammation height at 0, 1, 2, and 3 h
Result: Showed a significant reduction of paw height compared to control after 3 h.
分子量

384.41

Formula

C17H16N6O3S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
COX-2-IN-30
目录号:
HY-149269
需求量: